Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.13% 0.14% 1.002M --
Weighted Average Dividend Yield Turnover Ratio (Generic) 1 Year Fund Level Flows Max Drawdown (Since Inception)
-- -- 3.959M Upgrade

Basic Info

Investment Strategy
The Fund seeks to track the performance, before fees and expenses, of the BITA World BioPharma and Life Sciences Index. The Fund pays transaction costs, such as commissions, when it buys and sells securities. The Fund will invest at least 80% of the Funds net assets plus borrowings for investment purposes.
General
Security Type Exchange-Traded Fund
Equity Style --
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Global Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro World Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Global Health/Biotechnology Funds
Fund Owner Firm Name Portfolio Building Block
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Performance Versus Peer Group

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Peer Group Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Peer Group (NAV)
--
--
--
--
--
--
--
--

Annual Total Returns Versus Peers

Loading chart...
Name
2018
2019
2020
2021
2022
2023
2024
YTD
-8.71%
27.67%
15.90%
21.82%
-18.14%
23.79%
18.67%
20.61%
2.83%
23.22%
12.75%
19.59%
-4.93%
3.64%
0.55%
14.49%
--
--
--
--
-28.59%
7.55%
1.79%
2.23%
--
--
--
--
--
0.92%
-2.77%
28.12%
--
--
--
--
--
--
--
12.97%
As of December 20, 2025.

Asset Allocation

Type % Net
Cash --
Stock --
Bond --
Convertible --
Preferred --
Other --
No Data Available
View Asset Allocation
Start Trial

Basic Info

Investment Strategy
The Fund seeks to track the performance, before fees and expenses, of the BITA World BioPharma and Life Sciences Index. The Fund pays transaction costs, such as commissions, when it buys and sells securities. The Fund will invest at least 80% of the Funds net assets plus borrowings for investment purposes.
General
Security Type Exchange-Traded Fund
Equity Style --
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Global Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro World Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Global Health/Biotechnology Funds
Fund Owner Firm Name Portfolio Building Block
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Top Portfolio Holders